These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15224785)

  • 1. Deep venous thrombosis after high-dose intravenous immunoglobulin in the treatment of pemphigus vulgaris.
    Sheehan DJ; Lesher JL
    Cutis; 2004 Jun; 73(6):403-6. PubMed ID: 15224785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.
    Marie I; Maurey G; Hervé F; Hellot MF; Levesque H
    Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulins].
    Szép Z; Danilla T; Buchvald D
    Cas Lek Cesk; 2005; 144(10):700-3. PubMed ID: 16279438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of deep vein thrombosis and pulmonary thromboembolism after intravenous immunoglobulin therapy.
    Lee YJ; Shin JU; Lee J; Kim K; Kim WS; Ahn JS; Jung CW; Kang WK
    J Korean Med Sci; 2007 Aug; 22(4):758-61. PubMed ID: 17728525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications.
    Go RS; Call TG
    Mayo Clin Proc; 2000 Jan; 75(1):83-5. PubMed ID: 10630762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous and arterial thrombosis following administration of intravenous immunoglobulins.
    Paran D; Herishanu Y; Elkayam O; Shopin L; Ben-Ami R
    Blood Coagul Fibrinolysis; 2005 Jul; 16(5):313-8. PubMed ID: 15970713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment.
    Ahmed AR
    J Am Acad Dermatol; 2001 Nov; 45(5):679-90. PubMed ID: 11606916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of thromboembolic risk related to high-dose intravenous immunoglobulin treatment: a preliminary clinical study of 10 patients with autoimmune mucocutaneous blistering diseases.
    Mignogna MD; Fortuna G; Leuci S; Ruoppo E; Adamo D; Fedele S
    Clin Exp Dermatol; 2009 Mar; 34(2):145-50. PubMed ID: 19187294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of IVIg treatment in severe pemphigus vulgaris.
    Baum S; Scope A; Barzilai A; Azizi E; Trau H
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):548-52. PubMed ID: 16684282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IVIG therapy in pemphigus vulgaris has corticosteroid-sparing and immunomodulatory effects.
    Svecova D
    Australas J Dermatol; 2016 May; 57(2):141-4. PubMed ID: 26581165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic complications after intravenous immunoglobulin therapy in two patients.
    Emerson GG; Herndon CN; Sreih AG
    Pharmacotherapy; 2002 Dec; 22(12):1638-41. PubMed ID: 12495174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous immunoglobulin on prednisone dose in patients with pemphigus vulgaris.
    Mittmann N; Chan B; Knowles S; Mydlarski PR; Cosentino L; Shear N
    J Cutan Med Surg; 2006; 10(5):222-7. PubMed ID: 17234105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.
    Sami N; Qureshi A; Ahmed AR
    Eur J Dermatol; 2002; 12(2):174-8. PubMed ID: 11872417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful treatment of corticoid-resistant pemphigus with high-dose intravenous immunoglobulins].
    Sibaud V; Beylot-Barry M; Doutre MS; Beylot C
    Ann Dermatol Venereol; 2000 Apr; 127(4):408-10. PubMed ID: 10844264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic complications of intravenous immunoglobulin therapy in patients with neuropathy: a two-year study.
    Rajabally YA; Kearney DA
    J Neurol Sci; 2011 Sep; 308(1-2):124-7. PubMed ID: 21679973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris.
    Engineer L; Bhol KC; Ahmed AR
    J Am Acad Dermatol; 2000 Dec; 43(6):1049-57. PubMed ID: 11100022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatments with immunoglobulin and thrombotic adverse events].
    Darnige L; Lillo-Le Louët A
    Rev Med Interne; 2014 Jan; 35(1):39-44. PubMed ID: 24011913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal case of bilateral internal jugular vein thrombosis following IVIg infusion in an adolescent girl treated for ITP.
    Iroh Tam PY; Richardson M; Grewal S
    Am J Hematol; 2008 Apr; 83(4):323-5. PubMed ID: 17975805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris.
    Arnold DF; Burton J; Shine B; Wojnarowska F; Misbah SA
    Br J Dermatol; 2009 May; 160(5):1098-102. PubMed ID: 19222460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.